Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2025 · 10-Q
Revenue$15.93M$15.93M−43.8% vs Q3 2024 Net Income-$1.75M-$1.75MN/M vs Q3 2024 EPS Diluted-$0.05-$0.05N/M vs Q3 2024 Gross Profit$2,272,000−63.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,307,000N/M Free Cash Flowderived-$1,536,000N/M Margins · derivedGross margin14.3%−7.8 pt vs Q3 2024
Operating margin-9.9%−16.8 pt vs Q3 2024
Net margin-11.0%−16.9 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end